A Review of Mathematical Models for Tumor Dynamics and Treatment Resistance Evolution of Solid Tumors
Anyue Yin,Dirk Jan A.R. Moes,Johan G.C. van Hasselt,Jesse J. Swen,Henk-Jan Guchelaar +4 more
- Vol. 8, Iss: 10, pp 720-737
TLDR
The opportunities of a model‐based approach as discussed in this review can be of great benefit for future optimizing and personalizing anticancer treatment.Abstract:
Increasing knowledge of intertumor heterogeneity, intratumor heterogeneity, and cancer evolution has improved the understanding of anticancer treatment resistance. A better characterization of cancer evolution and subsequent use of this knowledge for personalized treatment would increase the chance to overcome cancer treatment resistance. Model-based approaches may help achieve this goal. In this review, we comprehensively summarized mathematical models of tumor dynamics for solid tumors and of drug resistance evolution. Models displayed by ordinary differential equations, algebraic equations, and partial differential equations for characterizing tumor burden dynamics are introduced and discussed. As for tumor resistance evolution, stochastic and deterministic models are introduced and discussed. The results may facilitate a novel model-based analysis on anticancer treatment response and the occurrence of resistance, which incorporates both tumor dynamics and resistance evolution. The opportunities of a model-based approach as discussed in this review can be of great benefit for future optimizing and personalizing anticancer treatment.read more
Citations
More filters
Book ChapterDOI
Emerging techniques in breast MRI
TL;DR: In this article , the authors focus on six emerging techniques that seek to quantitatively interrogate the physiological and biochemical properties of the breast, including dynamic contrast-enhanced MRI and magnetic resonance elastography.
Proceedings ArticleDOI
Indirect supervised fine-tuning of a tumor model parameter estimator neural network
TL;DR: In this paper , another supervised neural network was used to solve the applied differential equations faster with fewer algebraic steps than the traditionally used ODE solvers, which can be used in further research as an unconstrained optimization technique for parameter fitting.
Journal ArticleDOI
Memory effects on the proliferative function in the cycle-specific of chemotherapy
TL;DR: In this article, a generalized mathematical model of the breast and ovarian cancer is developed by considering the fractional differential equations with Caputo time-fractional derivatives, which shows that the time-evolution of the proliferating cell mass, the quiescent cell mass and the proliferative function are significantly influenced by their history.
Journal ArticleDOI
Modeling cancer’s ecological and evolutionary dynamics
Anuraag Bukkuri,Kenneth J. Pienta,Ian Hockett,Robert H. Austin,Emma U. Hammarlund,Sarah R. Amend,Joel Brown +6 more
TL;DR: In this article , a theoretical modeling framework, called the G -function, is presented to understand oncogenesis of cancer cells, which integrates both the ecology and evolution of cancer to understand cancerogenesis.
Journal ArticleDOI
Discrete ARMA Model Applied for Tumor Growth Inhibition Modeling and LQR-based Chemotherapy Optimization
TL;DR: An autoregressive moving average (ARMA) model for cancer tumor growth is estimated based on laboratory data of TGI in mice and was proven capable of describing with accuracy the tumor growth under single-agent chemotherapy.
References
More filters
BookDOI
The Case Study
TL;DR: On May 25, 1977, IEEE member, Virginia Edgerton, a senior information scientist employed by the City of New York, telephoned the chairman of CSIT's Working Group on Ethics and Employment Practices, having been referred to the committee by IEEE Headquarters.
Journal ArticleDOI
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Jonathan C. M. Wan,Charles E. Massie,Javier Garcia-Corbacho,Florent Mouliere,James D. Brenton,Carlos Caldas,Simon Pacey,Richard D. Baird,Nitzan Rosenfeld +8 more
TL;DR: The field is now in an exciting transitional period in which ctDNA analysis is beginning to be applied clinically, although there is still much to learn about the biology of cell-free DNA.
Journal ArticleDOI
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Luis A. Diaz,Luis A. Diaz,Richard Thomas Williams,Jian Wu,Jian Wu,Isaac Kinde,J. Randolph Hecht,Jordan Berlin,Benjamin L. Allen,Ivana Bozic,Johannes G. Reiter,Johannes G. Reiter,Martin A. Nowak,Kenneth W. Kinzler,Kelly S. Oliner,Bert Vogelstein +15 more
TL;DR: Results suggest that the emergence of KRAS mutations is a mediator of acquired resistance to EGFR blockade and that these mutations can be detected in a non-invasive manner, which explains why solid tumours develop resistance to targeted therapies in a highly reproducible fashion.
Journal ArticleDOI
Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing
Charissa Kim,Ruli Gao,Emi Sei,Rachel Brandt,Johan Hartman,Thomas Hatschek,Nicola Crosetto,Theodoros Foukakis,Nicholas Navin +8 more
TL;DR: The data showed that resistant genotypes were pre-existing and adaptively selected by NAC, while transcriptional profiles were acquired by reprogramming in response to chemotherapy in TNBC patients.
Book ChapterDOI
The Mathematical Model
TL;DR: The death rate per tumor cell due to immunological response is proportional to the total number of antigen-producing (tumor) cells; thus, the total death rate is quadratic.